SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
AVEO Oncology (Formerly known as AVEO Pharmaceuticals, Inc.) to Host Conference Call and Webcast to Review Phase 3 TIVO-1 Data Presented at American Society of Clinical Oncology